Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-11

Clinical Trial Update: Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Purified Vero Rabies Vaccine with two reference rabies vaccines in a simulated post-exposure regimen in adults; results completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Vero Rabies Vaccine (PVRV) (Purified Vero Rabies Vaccine)
  • Reference Rabies Vaccine 1 (Rabies vaccine, inactivated)
  • Reference Rabies Vaccine 2 (Rabies vaccine, inactivated)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Rabies (Healthy Volunteers) | Phase 3 | Status: COMPLETED | Results posted: 2022-03-11